While amyloid β plaques are hallmarks of Alzheimer’s disease (AD), recent research suggests that they aren’t the only players in the neurodegenerative disorder. Genome-wide association studies and RNA ...
The Brighterside of News on MSN
Experimental drug can sharply reduce amyloid beta's impact on Alzheimer’s
Early in Alzheimer’s disease, your brain can begin to change long before anyone notices a lost name or missed appointment.
This article is based on a poster originally authored by Malika Bsibsi, Catalina Gomez Puerto, Lieke Geerts, Matteo Zanella, Stefan Kostense, and Marijn Vlaming, presented at SfN 2024. The chronic ...
Amyloid-beta (A-beta) aggregates are tangles of proteins most notably associated with neurodegenerative diseases like Alzheimer’s. Despite its constant stint in the limelight, however, researchers ...
A protein notorious for its role in Alzheimer’s disease may hold the key to supercharging the aging immune system, according to new research. Scientists have found that a byproduct of amyloid-beta ...
Gefei Chen is also affiliated with Uppsala University. Every three seconds, someone in the world develops dementia. Alzheimer’s disease is the most common form of dementia, accounting for between 60% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback